Capital World Investors Boosts Holdings in Cigna Group $CI

Capital World Investors boosted its position in shares of Cigna Group (NYSE:CI) by 2.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 1,329,348 shares of the health services provider’s stock after purchasing an additional 37,680 shares during the quarter. Capital World Investors owned about 0.50% of Cigna Group worth $383,185,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CI. Harbor Capital Advisors Inc. grew its holdings in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares during the last quarter. Collier Financial purchased a new position in Cigna Group in the 3rd quarter worth approximately $34,000. Traub Capital Management LLC bought a new position in Cigna Group in the 2nd quarter valued at approximately $48,000. Twin Peaks Wealth Advisors LLC purchased a new stake in Cigna Group during the 2nd quarter valued at $52,000. Finally, CNB Bank boosted its stake in Cigna Group by 479.4% during the 3rd quarter. CNB Bank now owns 197 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 163 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

Shares of CI opened at $260.79 on Thursday. The firm has a market capitalization of $68.73 billion, a P/E ratio of 11.76, a PEG ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The business has a fifty day moving average of $280.01 and a 200 day moving average of $283.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. Cigna Group’s payout ratio is 28.13%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CI. Jefferies Financial Group boosted their price target on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Barclays decreased their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Piper Sandler reduced their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $330.42.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.